bioRxivCancer Biology
Comprehensive mapping of cell fates in microsatellite unstable cancer cells support dual targeting of WRN and ATR
D. Zong, N. C. Koussa, J. A. Cornwell, A. V. Pankajam, M. Kruhlak, N. Wong, R. Chari, S. D. Cappell, A. Nussenzweig
Abstract
Addiction to the WRN helicase is a unique vulnerability of human cancers with high levels of microsatellite instability (MSI-H). However, while prolonged loss of WRN ultimately leads to cell death, little is known about how MSI-H cancers initially respond to acute loss of WRN, knowledge that would be helpful for informing clinical development of WRN-targeting therapy, predicting possible resistance mechanisms, and identifying useful biomarkers of successful WRN inhibition. Here, we report the construction of an inducible ligand-mediated degradation system wherein the stability of endogenous WRN protein can be rapidly and specifically tuned, enabling us to track the complete sequence of cellular events elicited by acute loss of WRN function. We find that WRN degradation leads to immediate accrual of DNA damage in a replication-dependent manner that curiously did not robustly engage checkpoint mechanisms to halt DNA synthesis. As a result, WRN-degraded MSI-H cancer cells accumulate DNA damage across multiple replicative cycles and undergo successive rounds of increasingly aberrant mitoses, ultimately triggering cell death. Of potential therapeutic importance, we find no evidence of any generalized mechanism by which MSI-H cancers could adapt to near-complete loss of WRN. However, under conditions of partial WRN degradation, addition of low dose ATR inhibitor significantly increased their combined efficacy to levels approaching full inactivation of WRN. Overall, our results provided the first comprehensive view of molecular events linking upstream inhibition of WRN to subsequent cell death and suggested a potential therapeutical rationale for dual targeting of WRN and ATR.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Werner syndrome helicase is a selective vulnerability of microsatellite instability high tumor cells
S. Lieb, S. Blaha-Ostermann, … S. Woehrle·bioRxiv·Jan 26, 2019
- WRN Inhibition Leads to its Chromatin-Associated Degradation Via the PIAS4-RNF4-p97/VCP Axis
Fernando Rodríguez-Pérez, Dean E. Natwick, … Stephen E. Basham·Nature CommunicationsPeer-reviewed·Jul 18, 2024
- WRN Helicase is a Synthetic Lethal Target in Microsatellite Unstable Cancers
E. Chan, T. Shibue, … A. J. Bass·bioRxiv·Dec 21, 2018
- On-target mutations confer resistance to WRN helicase inhibitors in Microsatellite Unstable Cancer Cells.
Gabriele Picco, Yanhua Rao, … Mathew J. Garnett·bioRxiv·Dec 27, 2025
- Anticipating on-target resistance to WRN inhibitors in microsatellite unstable cancers
Mark E. Orcholski, Nancy Laterreur, … Raquel Cuella-Martin·bioRxiv·Jan 24, 2026
- Functional orthogonality of WRN inhibitor resistance enables alternating therapy and mutation-tolerant inhibitor design in MSI-H cancers
Guizhen Zhou, Dan Teng, … Mingyue Zheng·bioRxiv·Jun 12, 2026